Using oxytocin nasal spray to help adolescents lose weight
Official title: Oxytocin as a Neuroendocrine Therapy for Obesity in Youth
Run by Massachusetts General Hospital · NCT04551482 · Data updated 2026-11-12
This study is testing if a nasal spray with oxytocin can help teenagers aged 12-18 who are struggling with obesity to lose weight by reducing their appetite and boosting their metabolism.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 10 Years to 18 Years |
| Sex | All |
| Enrollment | 54 (estimated) |
| Sponsor | Massachusetts General Hospital Academic / other |
| Locations | 1 site (Boston, Massachusetts) |
| Status | Recruiting |
| Started | July 28, 2021 |
| Main results expected | March 31, 2027 |
| Study ends | May 31, 2027 |
| Registry record updated | November 4, 2026 |
| Trial ID | NCT04551482 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adolescents aged 12-18 years with obesity defined as a BMI at or above the 95th percentile for their age and gender.
✕Probably not a fit
Patients with active substance abuse, certain chronic health conditions, or those on specific weight-loss medications may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the effects of intranasal oxytocin on weight loss in adolescents aged 12-18 years with obesity. Participants will be randomly assigned to receive either oxytocin or a placebo for 12 weeks, with assessments of appetite, behavior, metabolism, and endocrine function. The study aims to determine if oxytocin can reduce caloric intake and increase energy expenditure, potentially improving metabolic health markers. Regular safety check-ins and follow-ups will ensure participant well-being throughout the trial.
Why it matters
Potential benefit: If successful, this treatment could provide a novel and effective weight loss option for adolescents struggling with obesity.
How similar studies have gone: While oxytocin has shown promise in adult obesity treatments, this specific application in adolescents is novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Males and Females, 10-18 years * Obesity (BMI ≥95th percentile for age and gender) * Willingness to maintain current diet and lifestyle for the duration of study participation Exclusion Criteria: * Current substance abuse * Use of prescription or over-the-counter drugs or dietary/herbal supplements that may affect weight if dose increased in the three months preceding the baseline visit and/or if they plan to increase the dose during the 18 weeks of study participation. * Greater than 5kg weight loss over 3 months; * Follows a nonstandard diet (e.g., Paleo, Atkins, raw diet, macrobiotic diet) * Cardiovascular disease * Prolonged QT interval * Chronic inflammatory bowel disease and other inflammatory conditions * Epilepsy * TSH \> 2.5 times upper limit of normal * Alanine transaminase (ALT) or aspartate transaminase (AST) \>2.5 times upper limit of normal * Creatinine \>1.5 mg/dl * Hyponatremia * Pregnancy/breastfeeding or refusal to use contraception not containing estrogen throughout the study if female and sexually active * MRI exclusion criteria such as the presence of a pacemaker or cerebral aneurysm clips * Weight \>450 lbs due to limits for MRI and DXA scanners * Type 1 Diabetes Mellitus or Type 2 Diabetes Mellitus if HbA1c \>8% * Active eating disorder
Where it's running
-
Massachusetts General Hospital
Boston, Massachusetts, United States Recruiting
Study contacts
- Principal investigator: Elizabeth Lawson, MD, MMSc — Massachusetts General Hospital
- Study coordinator: Elizabeth A Lawson, MD, MMSc
- Email: ealawson@partners.org
- Phone: 617-726-3870
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Mindfulness and meditation lactation education for mothers of premature NICU infants
This will test whether mindfulness and meditation training for mothers who are pumping for their premature NICU infants changes components of their breastmilk.
-
Replacing sugary sodas with flavored sparkling water for Black/African American and Latine teens with obesity
This trial will test whether swapping sugary sodas for unsweetened flavored sparkling water, gradually reduced-sugar sodas, or plain water can cut added sugar and improve health in Black/African American and Latine teens with obesity who prefer sweet drinks.
-
Digital program to help teens manage weight and healthy habits
This trial tries a multi-modal digital program—AI coaching, interactive platforms, gamified apps, and real-time feedback—to help overweight teens (ages 12–18, BMI ≥85th percentile) adopt healthier weight-control behaviors and avoid unhealthy practices.
-
National blood pressure screening for children in South Africa
This study is trying to find out what normal blood pressure levels are for children in South Africa so that doctors can better manage high blood pressure in kids, especially those of African descent.
-
Program to improve health and reduce substance use among Choctaw youth
This study is testing a nature-based program to help Choctaw youth aged 12-19 be more active, eat healthier, and reduce substance use by incorporating their cultural values.
-
Survey on bariatric surgery for adolescents
This study is trying to see how well laparoscopic adjustable gastric banding works for teenagers aged 14-20 who are having bariatric surgery, focusing on weight loss and any health issues that might come up.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.